DeuterOncology closes financing round to start lung cancer study
DeuterOncology, a clinical-stage drug development company, has closed €5.65 million ($6.1 million) series A financing,…
January 20, 2023 - 2 minutes
DeuterOncology, a clinical-stage drug development company, has closed €5.65 million ($6.1 million) series A financing,…